Dotmatics has acquired BioBright to create a unified offering that will help our customers accelerate their journey towards the Lab of the Future. This unique combination of the Dotmatics Scientific Informatics Platform with BioBright's Scientific Lab Data Automation Platform, will enable our customers to automate their laboratory data workflows and provide a modern data foundation for their next generation scientific data management and AI/ML driven analytics.
Automating data processing speeds cycle times and removes manual bottle necks especially in high-throughput experimentation.
Real-time, accurate data exchange speeds cycle times, protects IP and ensures the fidelity of results from externalized research.
Automating data processing removes error and provides cleaner data for better AI/ML resulting in better decisions and enhancing innovation.
Real-time collection of massive volumes of data enables entirely new classes of data science analytics that would not be possible with manual processing.
A modern data infrastructure allows scientists to gather all relevant project data driving innovation through fully informed data driven decision making.
This is an exciting milestone in the history of Dotmatics and also hugely significant for our customers and the wider industry. For the first time world-leading informatics and lab data automation platforms are being brought together under a single vendor. Through complementary technologies, shared scientific expertise and industry insight, we will dramatically accelerate Dotmatics’ ability to innovate and drive lab data automation. We are delighted to welcome our new BioBright colleagues to Dotmatics and look forward to working together to create a game-changing solution for our customers’ journey towards the Lab of the Future.Dr. Stephen Gallagher
All research organizations need to maximize the efficiency of their laboratory workflows while at the same time ensuring they have the highest quality data on which to make decisions. The data automation workflows that will be possible from the combination of Dotmatics and BioBright will be an important new offering to the industry to help address these challenges.Jarrod Medeiros
Director of Informatics and IT at Casma Therapeutics
Scientific research has moved from being process-driven to data-centric. Scientists are inferring the results of experiments by analyzing more data than ever, and real-time data processing of terabytes of data is enabling analyses which were simply not possible in the manual era. Companies that own the cleanest, best-annotated data will be the most successful in making ground-breaking discoveries within this new paradigm. We are excited to combine BioBright with Dotmatics to build out a unique end-to-end offering that will allow our customers to achieve their data-driven future.Charles Fracchia
CEO of BioBright